Search

everythinglearnresearchcommunity

for

Search:↓

Understanding the mouse hair cycle is crucial for cancer research.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Hormonal therapies are safe and effective for treating adult women's acne.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Using psychological treatments can help manage skin conditions along with regular medical care.

New drug delivery methods can make natural compounds more effective and stable.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Juniperus plants contain compounds with potential for developing various medical treatments.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

FDG PET/CT scans can change cancer treatment plans for dogs.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

AcSDKP may help prevent skin and hair aging and promote their growth.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.